NewGenIvf Group Limited (NIVF)

NewGenIvf Group Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	9.73	-0.47	0.11	0.14
Depreciation & Amortization	0.5	0.21	0.23	0.3
Stock-Based Compensation	0.05	0.03	-	-
Other Adjustments	-19.59	-0.27	-0.01	0.57
Change in Receivables	-0.12	-0.04	0	0.13
Changes in Inventories	-0.25	0.05	-0.08	-0.01
Changes in Accounts Payable	-0.52	1.13	0.07	0.06
Changes in Accrued Expenses	0.21	-6.75	-0.05	0.19
Changes in Income Taxes Payable	-0.01	0.01	-	-0.01
Changes in Unearned Revenue	0.05	0.06	-1.35	0.55
Changes in Other Operating Activities	-0.97	-2.21	-0.68	-0.21
Operating Cash Flow	-10.93	-8.26	-1.77	1.71
Capital Expenditures	-0.14	-0.05	-0.07	-0.09
Purchases of Investments	-1.76	-	-	-
Payments for Business Acquisitions	-1.05	-	-	-
Other Investing Activities	-4.61	-	-	-
Investing Cash Flow	-7.56	-0.05	-0.07	-0.09
Long-Term Debt Issued	6.84	8.58	-	0.13
Long-Term Debt Repaid	-0.5	-0.01	-0.01	-0.02
Net Long-Term Debt Issued (Repaid)	6.34	8.58	-0.01	0.11
Issuance of Common Stock	12.62	-	0.19	-
Net Common Stock Issued (Repurchased)	12.62	-	0.19	-
Other Financing Activities	0.03	0.1	1.7	-1.74
Financing Cash Flow	18.99	8.68	1.88	-1.63
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-0.21	0.04	-0.02	0.02
Net Cash Flow	0.51	0.36	0.05	-0.02
Free Cash Flow	-11.06	-8.32	-1.84	1.62
FCF Margin	-234.03%	-153.08%	-35.75%	27.19%
Free Cash Flow Per Share	-3.40	-69891.80	-19128.70	16841.40
Levered Free Cash Flow	15.09	0.49	-1.81	1.35
Unlevered Free Cash Flow	-11.86	-8.14	-1.89	0.94

Updated Mar 31, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q